Pharmaceutical manufacturers face unrelenting pressure to grow and protect market share for their products. At the same time, a host of obstacles stands in their way. Competing products vie for physician and patient attention. Economic woes make all healthcare-related costs more challenging for patients. Standard side effects can cause patients to doubt the effectiveness of their treatment.
Patient adherence and compliance programs can help manufacturers address these challenges, but even then, many manufacturers question how to launch the programs and manage them effectively. Join us as we explore these crucial issues with Jan Nielsen, Vice President of Clinical Services for ICS, and Pat Clinton, Editor-in-Chief for Pharmaceutical Executive magazine.